clinical study on the efficacy of Haritaki churna and Aragwadh phal majja churna in the management of vibandha with special reference to constipation in children

A comparative clinical study on the efficacy of Haritaki churna and Aragwadh phal majja churna in the management of vibandha with special reference to constipation in children - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110518

Enrollment

Registered

2026-05-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K638- Other specified diseases of intestine

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Children of either gender aged between 5 and 16 years. 2 Patients presenting with clinical features of functional constipation. 3 Written informed consent obtained from parents or legal guardians.

Exclusion criteria

Exclusion criteria: 1.Constipation due to organic causes (e.g., Hirschsprung s disease of anorectal malformations, hypothyroidism). 2.Intestinal obstruction or other surgical conditions. 3.Patients with severe systemic illness. 4.Patients currently on other laxative medications. 5.Children below the age of 5 years and above the age of 16 years

Design outcomes

Primary

Measure	Time frame
The conclusion will be drawn from the results and statistical analysis of the study to determine which of the two drugs, Haritaki or Aragwadh Phal Majja, is more effective and safer for the management of Vibandha in childrenTimepoint: 15 Days	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Arvind Chaurasia

Government Ayurvedic College And Hospital Patna

arvindschaurasia@gmail.com9835255180

Outcome results